Manufacturing Partnerships Ennaid Therapeutics has demonstrated a willingness to collaborate with contract manufacturers, as shown by the Catalent partnership on an antiviral program. This indicates a viable path for external manufacturing, formulation development, and regulatory support. A sales approach could focus on end-to-end manufacturing partnerships and scalable pilot production to support clinical programs, leveraging outside capabilities to compensate for small headcount.

Platform Versatility Proof of adaptability with a Zika focus and a COVID-19 collaboration suggests the core platform could target a broader set of antiviral threats, especially mosquito-borne and emerging viruses. This creates opportunities for co-development or licensing deals with infectious disease-focused companies or government programs seeking versatile antiviral platforms. Position Ennaid as a nimble partner able to pivot to new viral targets.

Funding Opportunities Current revenue indicates room for growth through partnerships and grant-driven development. Opportunities exist to engage with government programs and philanthropic funders for disease-focused antiviral programs, bridging funding gaps for early-stage clinical work. A BD pitch could emphasize milestone-based partnerships that de-risk development while expanding manufacturing reach.

Regional Collaboration Based in Alpharetta within the Atlanta biotech cluster, Ennaid has access to regional CROs, academic labs, and biotech accelerators. This ecosystem can accelerate preclinical and early clinical work through local partnerships and pilot studies. A sales approach could map local partners for rapid trial execution and regulatory support networks.

Licensing Potential Given the lean team and collaborative track record, licensing or exclusive co-development deals with larger pharma could quickly scale the program. Propose deal structures that secure manufacturing access and distribution channels while preserving strategic flexibility. Use Catalent collaboration as a proven reference to demonstrate capability and reliability.